This HTML5 document contains 112 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37662241
rdf:type
wikibase:Item
schema:description
article scientifique наукова стаття, опублікована в грудні 2013 научни чланак vedecký článok scientific article published on 02 December 2013 articolo scientifico videnskabelig artikel artigo científico vetenskaplig artikel article científic wissenschaftlicher Artikel vědecký článek مقالة علمية نشرت في 02 ديسمبر 2013 bilimsel makale wetenschappelijk artikel artículu científicu espublizáu en 2013
p:P577
wds:Q37662241-B18ADC31-75FF-4A25-A4BA-6AECD9C32CEB
wdt:P577
2013-12-02T00:00:00Z
p:P407
wds:Q37662241-2523ED29-A48E-491C-A311-A8632915F5C4
wdt:P407
wd:Q1860
p:P2860
wds:Q37662241-163E452F-C033-4872-A887-DC3C8405789F wds:Q37662241-15004243-8845-47B6-9223-A70101BC486A wds:Q37662241-055778EC-5002-4DF3-82B7-964FEEF691A4 wds:Q37662241-6E22B366-37B8-49E4-8974-9D8950A3C46A wds:Q37662241-8234DB5F-0B38-4F82-B1FB-448085234999 wds:Q37662241-5E9BFD53-173B-47E8-9B36-F91F94FF7EE9 wds:Q37662241-6A581E5B-3627-41AF-896F-35C36069F770 wds:Q37662241-477F0B70-F5A7-42B2-BE0C-6511CDBEC335 wds:Q37662241-562DB312-77A8-45CB-8BAA-AD67F9C3311C wds:Q37662241-434E1FF6-544A-4FEE-8B95-B3F0684EA6DB wds:Q37662241-E72C252B-C680-4BC2-A364-B072984F76E0 wds:Q37662241-D2ED0863-3D00-4DA4-BD20-469CAD77547C wds:Q37662241-9AB32D2F-6142-4968-A78C-0186A4C6D5C7 wds:Q37662241-AC1AD3FB-3377-494D-9C47-3C33A4770226 wds:Q37662241-97AFBC73-BD8C-49DB-9698-E8773DEE8CF2 wds:Q37662241-99827925-5F1B-4A8E-BFE5-BF378C8B6E5B
wdt:P2860
wd:Q44951979 wd:Q42790805 wd:Q82413670 wd:Q35248222 wd:Q72732640 wd:Q34336573 wd:Q43070030 wd:Q43182256 wd:Q81776925 wd:Q44919656 wd:Q35103028 wd:Q34627846 wd:Q34619839 wd:Q34679345 wd:Q80704615 wd:Q46726140
p:P2093
wds:Q37662241-D1B1206B-D493-4560-BE32-9C02B766BDCC wds:Q37662241-69749D0D-0B25-4639-AEF1-9B70E7E487C1 wds:Q37662241-5E097649-0F3F-496D-8FB6-F6C15702EE6E wds:Q37662241-29454350-08EF-46B2-9E98-DCC032DEF735 wds:Q37662241-2955E7D3-9559-47F6-81C4-92E9CA7A3969 wds:Q37662241-51A11795-97BB-456E-8C8A-72A0285413A7 wds:Q37662241-45F12727-596B-4F6B-8A72-54E1539520D3 wds:Q37662241-09B59E6A-4664-41A8-9736-1E5132F5F7BA wds:Q37662241-12C00FD9-384C-4C1A-95EE-F22A28EE887E
wdt:P2093
Louis Fehrenbacher Kathleen A Flynn Drew Seisler Charles L Loprinzi Grant C Lewis Rubina Qamar Shaker R Dakhil Axel Grothey Rui Qin
rdfs:label
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
skos:prefLabel
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
schema:name
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
p:P50
wds:Q37662241-9C6EADF2-2886-4590-BDFA-7B0A500EF09E
wdt:P50
wd:Q107069934
p:P1476
wds:Q37662241-E4CD2384-E0EF-4BBB-BE89-D0DF26C80910
wdt:P1476
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
p:P304
wds:Q37662241-9335CFE2-ADC8-46CD-A7E6-17C9D5F954D1
wdt:P304
997-1005
p:P31
wds:Q37662241-DEF9A6D2-3F3A-4958-92C5-41197EC99449
wdt:P31
wd:Q13442814
p:P921
wds:Q37662241-3CC1747C-BB6E-4BF6-B73A-F3563876BD59 wds:Q37662241-6EF713C6-B11D-4CA2-AB64-BCDCDDFE7A28 wds:Q37662241-E96609CA-5A81-40B9-9179-B753353448AB wds:Q37662241-18EA4636-C61B-4C66-862E-CC121A10AFB7 wds:Q37662241-e7bf6b76-f6e4-473c-9391-1b5760315172
wdt:P921
wd:Q422327 wd:Q269829 wd:Q660 wd:Q3338704 wd:Q7830379
p:P698
wds:Q37662241-898A79FD-E4AA-4EA0-93C7-8331DAC04E75
wdtn:P698
n11:24297951
wdt:P698
24297951
p:P1433
wds:Q37662241-12F98EF6-4D11-4597-A2C9-4D7F310CBB79
wdt:P1433
wd:Q400292
p:P433
wds:Q37662241-264C417A-46BF-4158-999E-BF4FB31E81F6
p:P478
wds:Q37662241-FBD4AFD9-9493-43EC-90FB-9ED5642FE6DF
wdt:P433
10
wdt:P478
32
p:P356
wds:Q37662241-F1652598-045B-4150-995D-64833FB57921
wdtn:P356
n12:JCO.2013.52.0536
wdt:P356
10.1200/JCO.2013.52.0536
p:P932
wds:Q37662241-72195C31-FA62-4DBB-83B0-06A34A6D9D3D
wdt:P932
3965262